Repurposing Immunomodulatory Drugs to Combat Tuberculosis

Repurposing Immunomodulatory Drugs to Combat Tuberculosis

Tuberculosis (TB) is an infectious disease caused by an obligate intracellular pathogen, Mycobacterium tuberculosis (M.tb) and is responsible for the maximum number of deaths due to a single infectious agent. Current therapy for TB, Directly Observed Treatment Short-course (DOTS) comprises multiple...

Full description

Bibliographic Details
Main Authors: Samreen Fatima, Ashima Bhaskar, Ved Prakash Dwivedi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
Mycobacterium tuberculosis
directly observed therapy short course
repurposed approved drugs
immunomodulators
T cells (Th1/Th2)
vaccine
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.645485/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.645485/full

Similar Items